| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,317 |
12,675 |
$1.45M |
| 81025 |
|
8,212 |
7,851 |
$1.40M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,448 |
5,770 |
$1.06M |
| 80053 |
Comprehensive metabolic panel |
7,747 |
6,779 |
$886K |
| 36415 |
Collection of venous blood by venipuncture |
4,653 |
3,282 |
$622K |
| 94010 |
|
873 |
871 |
$568K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,861 |
3,482 |
$553K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,919 |
2,891 |
$492K |
| 81001 |
|
10,774 |
9,961 |
$419K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,491 |
2,225 |
$397K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,943 |
4,095 |
$397K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,161 |
10,277 |
$373K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,127 |
4,710 |
$274K |
| 84702 |
|
2,269 |
2,109 |
$236K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,607 |
1,559 |
$202K |
| 85027 |
|
3,352 |
3,067 |
$186K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,964 |
4,620 |
$162K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,401 |
10,665 |
$144K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,355 |
1,319 |
$119K |
| 86900 |
|
1,269 |
1,238 |
$108K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,305 |
2,217 |
$101K |
| 87210 |
|
904 |
888 |
$92K |
| 76830 |
Ultrasound, transvaginal |
510 |
508 |
$83K |
| 86850 |
|
749 |
730 |
$80K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
633 |
633 |
$73K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,543 |
1,507 |
$71K |
| 84112 |
|
201 |
194 |
$61K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,583 |
1,502 |
$61K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,986 |
1,986 |
$61K |
| 76642 |
|
878 |
783 |
$58K |
| 70450 |
Computed tomography, head or brain; without contrast material |
862 |
841 |
$56K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,138 |
3,098 |
$52K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,193 |
1,189 |
$49K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
8,114 |
7,147 |
$46K |
| 71045 |
Radiologic examination, chest; single view |
1,951 |
1,848 |
$43K |
| 71046 |
Radiologic examination, chest; 2 views |
1,517 |
1,482 |
$42K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
993 |
932 |
$42K |
| G0378 |
Hospital observation service, per hour |
2,204 |
1,494 |
$41K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
24 |
24 |
$41K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
438 |
426 |
$40K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
960 |
779 |
$40K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,110 |
4,588 |
$38K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
222 |
219 |
$34K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
5,715 |
5,243 |
$33K |
| J3490 |
Unclassified drugs |
3,284 |
1,932 |
$31K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
182 |
179 |
$29K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,678 |
3,152 |
$22K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
120 |
112 |
$21K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
944 |
931 |
$20K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
159 |
157 |
$20K |
| 87077 |
|
324 |
315 |
$17K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,342 |
5,305 |
$15K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
168 |
120 |
$13K |
| 94761 |
|
267 |
267 |
$13K |
| 81003 |
|
296 |
294 |
$12K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,261 |
3,578 |
$11K |
| 76801 |
|
379 |
352 |
$10K |
| 96376 |
|
1,475 |
895 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
142 |
142 |
$9K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,252 |
3,917 |
$8K |
| 86901 |
|
1,287 |
1,257 |
$8K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
62 |
51 |
$8K |
| 83735 |
|
3,711 |
3,108 |
$7K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
14 |
14 |
$7K |
| 88307 |
|
147 |
146 |
$7K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
510 |
499 |
$5K |
| 82731 |
|
15 |
15 |
$5K |
| 87081 |
|
52 |
52 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,214 |
1,802 |
$4K |
| 84484 |
|
2,661 |
2,262 |
$4K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
49 |
48 |
$4K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
104 |
102 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
542 |
469 |
$4K |
| 88304 |
|
52 |
52 |
$4K |
| 77066 |
Tomosynthesis, mammo |
27 |
27 |
$4K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
98 |
90 |
$4K |
| 82570 |
|
531 |
447 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
607 |
585 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
107 |
96 |
$3K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
962 |
943 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
475 |
474 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
49 |
48 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,368 |
2,287 |
$2K |
| 88342 |
|
133 |
130 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,582 |
1,496 |
$2K |
| 84703 |
|
154 |
153 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,914 |
2,833 |
$2K |
| 73560 |
|
17 |
17 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,737 |
1,662 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,202 |
1,756 |
$1K |
| 93976 |
|
760 |
721 |
$1K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
251 |
230 |
$1K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
217 |
215 |
$791.86 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
313 |
228 |
$791.32 |
| 82550 |
|
109 |
93 |
$770.52 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
50 |
50 |
$769.36 |
| 76937 |
|
16 |
13 |
$758.36 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
68 |
67 |
$752.71 |
| 83690 |
|
3,148 |
2,913 |
$710.42 |
| 85610 |
|
473 |
447 |
$527.42 |
| 80069 |
|
13 |
12 |
$486.12 |
| 84156 |
|
576 |
465 |
$459.11 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
305 |
268 |
$457.70 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14 |
14 |
$368.16 |
| 85379 |
|
185 |
179 |
$256.96 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
904 |
891 |
$91.12 |
| 86803 |
|
26 |
26 |
$63.30 |
| 83880 |
|
87 |
81 |
$37.94 |
| 84100 |
|
101 |
74 |
$26.36 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
303 |
293 |
$23.25 |
| 83605 |
|
143 |
136 |
$15.40 |
| 87186 |
|
89 |
88 |
$7.57 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
586 |
585 |
$6.72 |
| 85730 |
|
200 |
187 |
$6.16 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
127 |
125 |
$0.90 |
| 84550 |
|
464 |
400 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
46 |
46 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
815 |
699 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
54 |
39 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
235 |
100 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
210 |
181 |
$0.00 |
| 59025 |
Fetal non-stress test |
64 |
58 |
$0.00 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
39 |
39 |
$0.00 |
| 80076 |
|
18 |
16 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
12 |
12 |
$0.00 |
| 99152 |
|
20 |
20 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
47 |
15 |
$0.00 |
| A4311 |
Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) |
13 |
13 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
18 |
12 |
$0.00 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
27 |
26 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
16 |
15 |
$0.00 |
| 83615 |
|
361 |
311 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
150 |
133 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
27 |
25 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
37 |
37 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
54 |
54 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
144 |
143 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
50 |
41 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
63 |
63 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
69 |
69 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
14 |
14 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
59 |
59 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
37 |
28 |
$0.00 |